I really don't want to be a doctor

Chapter 514 GCP Review Passed!

As the influence of Shenzhou Laboratories increases, there will be more and more top laboratories that require mutual visits.

Jing Xiaoran heard the words and said, "Let's choose five laboratories abroad, and ten laboratories in China. However, the exchanges and visits must not interfere with the normal operation of our laboratories. At the same time, those who intend to go to other laboratories For those who communicate in the laboratory, please agree as much as possible and let them out."

"Ah? This..." Zhu Xianqing asked suspiciously, "Xiao Ran, our laboratory can be said to be the top laboratory in China at present, and everyone will not think about going to other places, but there may still be many laboratories abroad. People want to go. If you just let it go, I'm afraid..."

"If others want to leave, we can't keep them." Jing Xiaoran smiled, "And as long as the core personnel of the entire laboratory are there, the Shenzhou Laboratory can continue to develop. What's more, if there is a turnover of personnel, we can also absorb more Great talent."

Although Zhu Xianqing did not agree with some of Jing Xiaoran's views, he knew that as long as Jing Xiaoran, no matter how many people were left in the laboratory, he could still develop the laboratory.

Who would have imagined that there was an empty laboratory in the Shenzhou Laboratory two years ago, and they had to clean it themselves.

……

With the official launch of the immune checkpoint inhibitor of Shenzhou Laboratory in the United States, and with the promotion and momentum of Pfizer, the entire tumor field is suddenly flooded with immune checkpoint inhibitors!
When the first batch of tumor patients in the United States used immune checkpoint inhibitors, this momentum became more and more powerful!
Jing Xiaoran still underestimated that this past life was rated as the most scientifically advanced medicine in the 21st century!

The effect of immune checkpoint inhibitors is surprisingly good, especially for those patients with advanced tumors, which can obviously improve survival!

In the field of tumors, as long as it can increase the survival time by a few days, it is a magic drug, not to mention that immune checkpoint inhibitors can shrink tumors and prolong survival time by several months!

Pfizer is urging the Shenzhou laboratory every day to make Jing Xiaoran step up the production of immune checkpoint inhibitors.

A course of immune checkpoint inhibitors will cost at least hundreds of thousands of Huaxia coins!
Even so, medicines are still in short supply!
Pfizer Kong looked at this treasure mountain, but he couldn't eat it. He was really anxious!

AstraZeneca is also jealous of the profits of Shenzhou Laboratories, but there is no way, their Phase III clinical trials are not over yet.

"Xiao Ran, I'd better go to America myself."

Facing the huge gap in the United States, Zhu Xianqing decided to go to the United States himself to assist Shenzhou Lab in establishing an American production line.

"Alright." Jing Xiaoran pondered for a long time, this is the best way at present.

"Mr. Zhu, you just happened to find Hong Sheng and give him this file." Jing Xiaoran pulled out a folder from the desk drawer, "Last time he was in a hurry, I forgot to give it to him."

"no problem."

After Zhu Xianqing left, everything about Shenzhou Laboratory fell on Jing Xiaoran's shoulders.

After letting go of the shopkeeper for too long, Jing Xiaoran found that he had to deal with too many things every day!

Every few days, I have to listen to the experimental reports of various experimental groups, and entertain visiting laboratories from all over the country.

Shenzhou Laboratory is no longer an unknown "small workshop" in the past. The emergence of immune checkpoint inhibitors established the top position of Shenzhou Laboratory!
"President Jing, this is the content of the GCP review I discussed with Zhu Xianqing earlier."

Su Zhe from the Fancheng GCP Branch suddenly sent a message to Jing Xiaoran about the review of the immune checkpoint inhibitor GCP.

Originally, Zhu Xianqing and Su Zhe were in charge of this matter, but when Zhu Xianqing went to the United States, it could only fall on Jing Xiaoran's head.

"Teacher Su, I'd rather have someone else talk to you. It's not very good for me to talk to you about this." Jing Xiaoran said.

"No need." Su Zhe immediately sent a message, "Actually, before Zhu Xianqing left, he had already done all the GCP review, and now I just let you take a look."

"Really?" Jing Xiaoran's eyes lit up.

Doesn't this mean that the GCP audit has passed?
Flipping through the documents sent by Su Zhe, Jing Xiaoran showed a long-lost smile.

The GCP audit for immune checkpoint inhibitors has finally passed!
"President Jing, we really hope that you can pass the review as soon as possible!" Su Zhe sighed, "The pressure from the leaders above is too great! In the United States, your drug production is in full swing, and we still don't release it in China. That's really true. I can't justify it!"

Jing Xiaoran smiled and said, "Thank you, Mr. Su, for your help during this time."

"Hey, it's all my job." Su Zhe suddenly changed the subject, "President Jing, are your immune checkpoint inhibitors really magical?"

"How should I put it?" Jing Xiaoran paused, "Immunotherapy is a new type of anti-tumor method, and it works very well for some specific tumors. But for most tumors, the first choice must still be conventional treatment. .If the conventional treatment fails, or the tumor has progressed to the middle and late stage, at this time, immunotherapy may be a new option!"

Immune checkpoint inhibitors have a wide range of applications and are suitable for most solid tumors and even some hematological tumors.

But as the developer of immune checkpoint inhibitors, Jing Xiaoran will definitely not make myths about this drug.

Currently, the best indications for immune checkpoint inhibitors are melanoma and non-small cell lung cancer.

Of course, with the launch of the drug and the progress of Phase IV clinical trials, more indications will be developed one after another.

"President Jing, I have a relative who has lung cancer, and it is now in the middle and late stages." Su Zhe said, "I have undergone surgery, radiation and chemotherapy, but the effect is not obvious. I want him to try yours. Immune checkpoint inhibitors."

Jing Xiaoran thought for a while and said, "Teacher Su, let me give you a contact information. He is Dr. Feng from Fancheng Cancer Hospital. At the beginning, the clinical trials of immune checkpoint inhibitors were carried out very well in their department. You go and see him."

"Thank you, President Jing!" Su Zhe was very excited.

This one more way means that there is one more hope of life!

……

The news that the immune checkpoint inhibitor passed the GCP review did not cause too much enthusiasm in China.

This is the exact opposite of the overwhelming propaganda in the United States, it is more like a kind of self-indulgence!
Only in the field of oncology pharmacy in Huaxia, most of the doctors and R&D personnel are very happy.

Especially the oncologists in Fancheng City, because they have seen the benefits of this drug, have been looking forward to the launch of immune checkpoint inhibitors.

(End of this chapter)